Cargando…

Current Status and Future Perspectives of Liquid Biopsy in Small Cell Lung Cancer

Approximately 19% of all cancer-related deaths are due to lung cancer, which is the leading cause of mortality worldwide. Small cell lung cancer (SCLC) affects approximately 15% of patients diagnosed with lung cancer. SCLC is characterized by aggressiveness; the majority of SCLC patients present wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mondelo-Macía, Patricia, García-González, Jorge, León-Mateos, Luis, Castillo-García, Adrián, López-López, Rafael, Muinelo-Romay, Laura, Díaz-Peña, Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825645/ https://www.ncbi.nlm.nih.gov/pubmed/33430290 http://dx.doi.org/10.3390/biomedicines9010048

Ejemplares similares

Circulating Free DNA and Its Emerging Role in Autoimmune Diseases
por: Mondelo-Macía, Patricia, et al.
Publicado: (2021)

Plasma cell-free DNA and circulating tumor cells as prognostic biomarkers in small cell lung cancer patients
por: Mondelo-Macía, Patricia, et al.
Publicado: (2022)

Clinical potential of circulating free DNA and circulating tumour cells in patients with metastatic non‐small‐cell lung cancer treated with pembrolizumab
por: Mondelo‐Macía, Patricia, et al.
Publicado: (2021)

Epigenetic Landscape of Liquid Biopsy in Colorectal Cancer
por: Rodriguez-Casanova, Aitor, et al.
Publicado: (2021)

Liquid Biopsy in Oral Cancer
por: Lousada-Fernandez, Fatima, et al.
Publicado: (2018)

Top-of-the-art cytometry as a novel tool to aid in lung cancer immunotherapy
por: Mondelo-Macía, Patricia, et al.
Publicado: (2023)

Detection of MET Alterations Using Cell Free DNA and Circulating Tumor Cells from Cancer Patients
por: Mondelo-Macía, Patricia, et al.
Publicado: (2020)

Liquid Biopsy in Endometrial Cancer: New Opportunities for Personalized Oncology
por: Muinelo-Romay, Laura, et al.
Publicado: (2018)

Liquid Biopsy for Monitoring EC Patients: Towards Personalized Treatment
por: Piñeiro-Pérez, Raquel, et al.
Publicado: (2022)

Clinical Application of Circulating Tumour Cells in Prostate Cancer: From Bench to Bedside and Back
por: León-Mateos, Luis, et al.
Publicado: (2016)

Liquid biopsy in cholangiocarcinoma: Current status and future perspectives
por: Rompianesi, Gianluca, et al.
Publicado: (2021)

Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer
por: García-Foncillas, Jesús, et al.
Publicado: (2018)

Improving the Management of Endometrial Cancer Patients through the Use of Liquid Biopsy Analyses: A Case Report
por: Casas-Arozamena, Carlos, et al.
Publicado: (2022)

Liquid Biopsy: Current Status and Future Perspectives
por: Baev, Vesselin, et al.
Publicado: (2023)

Circulating Tumor Cells Characterization Revealed TIMP1 as a Potential Therapeutic Target in Ovarian Cancer
por: Abreu, Manuel, et al.
Publicado: (2020)

Clinicopathological Profiles Associated with Discordant RAS Mutational Status between Liquid and Tissue Biopsies in a Real-World Cohort of Metastatic Colorectal Cancer
por: Brozos-Vázquez, Elena, et al.
Publicado: (2023)

Immunotherapy in patients with brain metastasis: advances and challenges for the treatment and the application of circulating biomarkers
por: Brozos-Vázquez, E. M., et al.
Publicado: (2023)

Biosensors for the Detection of Circulating Tumour Cells
por: Costa, Clotilde, et al.
Publicado: (2014)

Current Status of CTCs as Liquid Biopsy in Lung Cancer and Future Directions
por: Zhang, Zhuo, et al.
Publicado: (2015)

Liquid biopsy in hematological malignancies: current and future applications
por: Talotta, Donatella, et al.
Publicado: (2023)

Current and Future Perspectives of Cell-Free DNA in Liquid Biopsy
por: Liu, Shicai, et al.
Publicado: (2022)

Genomic Profiling of Uterine Aspirates and cfDNA as an Integrative Liquid Biopsy Strategy in Endometrial Cancer
por: Casas-Arozamena, Carlos, et al.
Publicado: (2020)

Current status and future perspectives of liquid biopsy in non-small cell lung cancer
por: Chang, Sunhee, et al.
Publicado: (2020)

The Current Status of the Liver Liquid Biopsy in MASH Related HCC: Overview and Future Directions
por: Ugonabo, Onyinye, et al.
Publicado: (2023)

Improving circulating tumor cells enumeration and characterization to predict outcome in first line chemotherapy mCRPC patients
por: León-Mateos, Luis, et al.
Publicado: (2017)

Longitudinal CTCs gene expression analysis on metastatic castration-resistant prostate cancer patients treated with docetaxel reveals new potential prognosis markers
por: Pereira-Veiga, Thais, et al.
Publicado: (2021)

Salivary DNA Methylation as an Epigenetic Biomarker for Head and Neck Cancer. Part I: A Diagnostic Accuracy Meta-Analysis
por: Rapado-González, Óscar, et al.
Publicado: (2021)

Extracellular Vesicles-Based Biomarkers Represent a Promising Liquid Biopsy in Endometrial Cancer
por: Herrero, Carolina, et al.
Publicado: (2019)

Liquid Biopsies in Head and Neck Cancer: Current State and Future Challenges
por: Kong, Lingyi, et al.
Publicado: (2021)

Liquid Biopsy in Prostate Cancer Management—Current Challenges and Future Perspectives
por: Crocetto, Felice, et al.
Publicado: (2022)

Analysis of Killer Immunoglobulin-Like Receptor Genes in Colorectal Cancer
por: Diaz-Peña, Roberto, et al.
Publicado: (2020)

Association of Salivary Human Papillomavirus Infection and Oral and Oropharyngeal Cancer: A Meta-Analysis
por: Rapado-González, Óscar, et al.
Publicado: (2020)

Global Gene Expression Characterization of Circulating Tumor Cells in Metastasic Castration-Resistant Prostate Cancer Patients
por: León-Mateos, Luis, et al.
Publicado: (2020)

Liquid Biopsy in Early-Stage Lung Cancer: Current and Future Clinical Applications
por: Vandekerckhove, Olivia, et al.
Publicado: (2023)

EGFR-Based Immunoisolation as a Recovery Target for Low-EpCAM CTC Subpopulation
por: Vila, Ana, et al.
Publicado: (2016)

A Novel Saliva-Based miRNA Signature for Colorectal Cancer Diagnosis
por: Rapado-González, Óscar, et al.
Publicado: (2019)

Analysis of a Real-World Cohort of Metastatic Breast Cancer Patients Shows Circulating Tumor Cell Clusters (CTC-clusters) as Predictors of Patient Outcomes
por: Costa, Clotilde, et al.
Publicado: (2020)

Liquid biopsy in non-small cell lung cancer—current status and future outlook—a narrative review
por: Smolle, Elisabeth, et al.
Publicado: (2021)

Current status of liquid biopsies for the detection and management of prostate cancer
por: Lu, Yi-Tsung, et al.
Publicado: (2019)

Current status of molecular diagnostic approaches using liquid biopsy
por: Takahashi, Kenji, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9l7f6jl67md8crhps0qd4jmd7i